One would think that with a proven concept and FDA approval expected at the end of the year/ early next year there will be some interest in the stock/ price appreciation.
Hopefully interest will grow as we approach FDA approval.
Ann: Appendix 4C - Quarterly Report and Business Update, page-2
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
-0.015(3.33%) |
Mkt cap ! $88.24M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 43.5¢ | $57.78K | 131.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 517 | 1 |
View Market Depth
| Last trade - 15.06pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
43.5¢ |
Change
-0.015 ( 2.25 %) |
||||
| Open | High | Low | Volume | ||
| 44.0¢ | 44.0¢ | 43.5¢ | 15732 | ||
| Last updated 15.06pm 12/06/2024 ? | |||||
| IMR (ASX) Chart |